Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Raxone®/Catena® (idebenone)
Rituximab product approval information - Licensing action
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
New Drugs Online report for idebenone
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Receptos doses first patient in Phase 2 trial for RPC1063 in ulcerative colitis
Zebrafish myelination: a transparent model for remyelination?
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US (MANAGE)
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.

Pages